Terry Wright, DPM
Foot Surgery · Arlington, TXNPI 1922068220
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Kerecis Limited at 30.3% of the total. Reporting peaked in 2024 at $4,477 and has fallen 70.8% since, to $1,305 in 2025.
Across 164 payments — averaging $69.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$3K
- Treace Medical Concepts, Inc.$2K
- Musculoskeletal Transplant Foundation Inc.$2K
- Trilliant Surgical LLC.$643
- Amgen$426
- Smith+Nephew$384
- plus $2K from 28 others
What the payments were for
- Travel & lodging$5,54849%
- Food & beverage$5,71250%
- Education$1171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 13 | $3,447 |
| Treace Medical Concepts, Inc. | 15 | $2,303 |
| Musculoskeletal Transplant Foundation Inc. | 14 | $1,875 |
| Trilliant Surgical LLC. | 3 | $643 |
| Amgen(2 entities) | 15 | $426 |
| Smith+Nephew | 25 | $384 |
| Paratek Pharmaceuticals, Inc. | 14 | $379 |
| Melinta Therapeutics, LLC | 6 | $187 |
| Mimedx Group, Inc. | 7 | $177 |
| Polynovo North America LLC | 3 | $175 |
| Pylant Medical | 2 | $159 |
| Merck | 11 | $156 |
| Paragon 28, Inc. | 1 | $149 |
| Nevro Corp. | 7 | $148 |
| Davol Inc. | 2 | $115 |
| Next Science LLC | 1 | $106 |
| Organogenesis Inc. | 1 | $98 |
| Medtronic(2 entities) | 3 | $60 |
| Arthrosurface Incorporated | 2 | $41 |
| Johnson & Johnson | 2 | $37 |
| Stryker | 1 | $35 |
| Integra Lifesciences Corporation | 1 | $34 |
| Orthofix Medical, Inc. | 2 | $29 |
| Bioventus LLC | 1 | $29 |
| Nabriva Therapeutics, PLC | 2 | $24 |
| Biowound Solutions, Inc. | 2 | $23 |
| Access Pro Medical, LLC | 1 | $23 |
| Abbott | 1 | $22 |
| Averitas Pharma Inc. | 1 | $18 |
| Baudax Bio Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Acell, Inc. | 1 | $14 |
| Arteriocyte Medical Systems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$9,756
- Kerecis Omega3 SurgiClose$4,736
- Lapiplasty System$2,149
- Kerecis Omega3 GraftGuide$957
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$643
- Kerecis SurgiClose$467
- KRYSTEXXA$240
- Portfolio$149
- VERSAJET II$125
- Novosorb BTM$122
- Kerecis GraftGuide$117
- NUZYRA$117
- Xperience$106
- BlastX$106
- Baxdela$103
How this compares
$11,377 in reported general payments places this provider in the 85th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 119 | $1,113 |
| Clotrimazole | 24 | $706 |
| Ammonium Lactate | 19 | $461 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $358 |
| Pentoxifylline | 21 | $323 |
| Terbinafine Hcl | 18 | $297 |
| Cephalexin | 38 | $241 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $223 |
| Levofloxacin | 20 | $114 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Arlington
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.